FDA Drug Safety Podcast: FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy

On April 26, 2016 FDA announced that it is evaluating the results of a Danish study that conclude there is a possible increased risk of miscarriage with the use of oral fluconazole (brand name Diflucan) for yeast infections.
Source: FDA Drug Safety Podcasts